The pathophysiological role of MiRNAs in heart failure - Takeaways - MDSpire

The pathophysiological role of MiRNAs in heart failure

  • By

  • Kun Lian

  • Qing Qi

  • Lichong Meng

  • Xin Zhu

  • Yubin Zhang

  • Yichang Xu

  • Zhiguang Song

  • Lin Li

  • Siyuan Hu

  • Zhixi Hu

  • June 3, 2026

  • 0 min

Share

  • 1

    Heart failure (HF) is characterized by myocyte loss, maladaptive remodeling, and energetic failure, posing a significant global health challenge.

  • 2

    MicroRNAs (miRNAs) are key post-transcriptional regulators that influence apoptosis, autophagy, fibrosis, inflammation, and energy metabolism in HF.

  • 3

    The study identified a complex regulatory system of miRNAs that affects myocardial survival, remodeling, and energy balance.

  • 4

    Despite the potential of miRNAs as biomarkers and therapeutic agents for HF, their clinical application remains in early exploration.

  • 5

    Further rigorous clinical studies are necessary to confirm the diagnostic value and therapeutic potential of miRNAs in heart failure.

Original Source(s)

The pathophysiological role of MiRNAs in heart failure

  • by Kun Lian, Qing Qi, Lichong Meng, Xin Zhu, Yubin Zhang, Yichang Xu, Zhiguang Song, Lin Li, Siyuan Hu, Zhixi Hu

  • June 3, 2026

Related Content

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions

Heart failure risk prediction based on machine learning and interpretability analysis